RISKS OF LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTION
- 1 January 1982
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 319 (8263) , 64-68
- https://doi.org/10.1016/s0140-6736(82)90211-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Double Blind Study of Dicumarol Prophylaxis in Coronary Heart DiseaseActa Medica Scandinavica, 2009
- EFFICACY OF ANTICOAGULATION IN THE U.K.The Lancet, 1981
- ANTICOAGULANT CONTROL IN THE NETHERLANDSThe Lancet, 1981
- CONTROL OF ANTICOAGULANT THERAPYThe Lancet, 1981
- ANTICOAGULANTS AND MYOCARDIAL INFARCTIONThe Lancet, 1981
- ANTICOAGULANTS IN CORONARY HEART DISEASE—RETROSPECT AND PROSPECTThe Lancet, 1981
- A DOUBLE-BLIND TRIAL TO ASSESS LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- Neurological Complications of Anticoagulation TherapyArchives of internal medicine (1960), 1979
- Sudden death from stroke.Stroke, 1977
- THROMBOTEST A NEW METHOD FOR CONTROLLING ANTICOAGULANT THERAPYThe Lancet, 1959